HALF YEAR RESULTS Double-digit revenue growth EBITDA profit

Paris, France and Camberley, UK – 26 September 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces unaudited results for the six months ended 30 June 2019.

http://novacyt.com/wp-content/uploads/2019/09/Novacyt-half-year-2019-results-PR-25-9-19-FINAL-ENGLISH.pdf